Haifeng Jiang Selected Research

Haifeng Jiang Research Topics

Disease

11	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2011
7	Heroin Dependence (Heroin Abuse) 12/2023 - 01/2012
7	Opioid-Related Disorders (Opiate Addiction) 12/2023 - 02/2012
5	Neoplasms (Cancer) 01/2024 - 11/2017
5	Inflammation (Inflammations) 01/2024 - 01/2019
4	Cognitive Dysfunction 01/2021 - 01/2016
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021 - 06/2013
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2016
3	Infections 03/2023 - 06/2013
2	Rheumatoid Arthritis 03/2023 - 11/2021
2	Arthritis (Polyarthritis) 02/2023 - 03/2022
2	Schizophrenia (Dementia Praecox) 01/2022 - 01/2020
2	Glioma (Gliomas) 02/2021 - 01/2021
2	Carcinogenesis 10/2020 - 03/2011
2	Hallucinations (Hallucination) 02/2018 - 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Esophageal Squamous Cell Carcinoma 01/2024
1	Hyperglycemia 10/2023
1	Stroke (Strokes) 10/2023
1	Reperfusion Injury 10/2023
1	Cerebral Infarction 10/2023
1	Brain Ischemia (Cerebral Ischemia) 10/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 07/2023
1	Carcinoma (Carcinomatosis) 03/2023
1	Virus Diseases (Viral Diseases) 03/2023
1	Experimental Arthritis 02/2023
1	Tuberculosis (Tuberculoses) 01/2022
1	Tetraploidy 07/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Residual Neoplasm 01/2021
1	Fibrosis (Cirrhosis) 10/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2020
1	COVID-19 01/2020
1	Nasopharyngitis 03/2019
1	Gambling (Pathological Gambling) 06/2018
1	Memory Disorders (Memory Loss) 01/2018
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 01/2016
1	Phobic Disorders (Phobia) 07/2015
1	Paranoid Disorders (Paranoia) 07/2015

Drug/Important Bio-Agent (IBA)

7	Methadone (Dolophine)FDA LinkGeneric 12/2023 - 02/2012
7	Heroin (Diamorphine)IBA 02/2016 - 01/2011
6	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 01/2016
5	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2023 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2011
3	Long Noncoding RNAIBA 11/2021 - 10/2020
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016 - 07/2015
2	CollagenIBA 02/2023 - 03/2022
2	Therapeutic UsesIBA 02/2023 - 01/2012
2	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 02/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	Metformin (Glucophage)FDA LinkGeneric 10/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2023
1	InterleukinsIBA 07/2023
1	erucylphosphocholineIBA 03/2023
1	Chemokine ReceptorsIBA 03/2023
1	Capsid Proteins (Capsid Protein)IBA 03/2023
1	piperineIBA 03/2023
1	Antiviral Agents (Antivirals)IBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2022
1	Clozapine (Clozaril)FDA LinkGeneric 01/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Prescription DrugsIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 11/2021
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	Chimeric Antigen ReceptorsIBA 07/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Protons (Proton)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Dynamins (Dynamin)IBA 01/2020
1	Naloxone Drug Combination Buprenorphine FDA Link 03/2019
1	Opioid Analgesics (Opioids)IBA 03/2019
1	TabletsIBA 03/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	candesartanIBA 01/2019
1	Type 1 Angiotensin ReceptorIBA 01/2019
1	DDTIBA 06/2018
1	Nitrous Oxide (Laughing Gas)IBA 02/2018
1	IodineIBA 11/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	cyclopropapyrroloindoleIBA 07/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2013
1	Indicators and Reagents (Reagents)IBA 06/2013
1	Prostaglandins EIBA 01/2012
1	CarrageenanIBA 01/2012

Therapy/Procedure

5	Therapeutics 12/2023 - 03/2011
2	Immunotherapy 01/2022 - 07/2021
1	Transcranial Magnetic Stimulation 01/2022
1	Secondary Prevention 07/2020